Schizophrenia Medications
-
NEWS AND INFORMATION
 
Nature Schizophrenia Special

Schizophrenia Special in Nature Journal

by Staff Memberon May 22, 2014
Phil Campbell,  the editor-in-chief of the prestigious and high quality scientific journal “Nature,” (based in the UK) has long been interested in schizophrenia and mental health concerns.  I’ve met him and discussed this interest last year when he was visiting the United States.  He is one of the founding members of of an important new […]
Columbia University Schizophrenia Study

New Study of Long-Acting Injectable Antipsychotics Finds Haloperidol an Effective, Less-Expensive Option

by Staff Memberon May 22, 2014
A new study done by Columbia University of long-acting injectable antipsychotics for people with schizophrenia found that the newer, second-generation, medication paliperidone palmitate (Brand name Invega Sustenna by Janssen Pharmaceuticals) was no more effective than the older, less expensive haloperidol decanoate. This was so, even though the doses of the older medication given in the […]

crime_image

Antipsychotic Use Associated with 50% Reduced Rate of Violent Crime

by Staff Memberon May 13, 2014
While people with schizophrenia are much more likely to be victims of criminal behavior than perpetrators, there is a small percentage of people who have schizophrenia that are more violent; especially those who have a history of violence and who are abusing drugs or alcohol, and in those cases it is family members who are […]
Newdrugs-graphic

Over 30 New Medications in Development for Schizophrenia

by Staff Memberon May 6, 2014
American biopharmaceutical research companies are currently developing almost 36 new medications for schizophrenia, and a total of 119 new medicines targeting mental health disorders, according to a new document by the Pharmaceutical Research and Manufacturers of America (PhRMA), the industry marketing / advocacy organization for pharmaceutical and biotech companies in the USA. Some of the drugs listed […]

Schizophrenia Newsbites

Schizophrenia News Watch – interesting newsbites from around the globe

by Staff Memberon April 28, 2014
With this new posting on “Schizophrenia News Watch” – we are initiating a periodic summary of interesting schizophrenia-related news from around the globe.  In these postings we will provide short summaries and links to schizophrenia-related news, videos and presentations from around the world. Closer than ever to a cure for Schizophrenia: This is a good […]
www.rethink.org_media_1030280_investing_in_recovery.pdf

New Report Demonstrates the Cost Effectiveness of Early Treatment

by Staff Memberon April 12, 2014
There has been a great deal of clinical research in the past decade that has shown that the sooner that people who have psychosis or schizophrenia are treated, the better their long term outcome or prognosis.  So getting people into treatment as quickly as possible (when symptoms start to appear) is extremely important. Despite this […]

Minerva_Neuroscience

Minerva Neurosciences Raising $69 Million to Fund New Schizophrenia Medications

by Staff Memberon April 10, 2014
Minerva Neurosciences today filed to raise $69 million via an initial public offering (IPO).  The proceeds from this fund raising will be used to further develop and test their new drug candidates that are targeted at schizophrenia, depression and other mental illnesses.  We at schizophrenia.com think that its great to see new medications being developed […]
medicine.image

Cannabis-Derivative a Potential New Schizophrenia Treatment

by Nina Flanaganon April 8, 2014
There have been many research studies suggesting that marijuana may increase risk of schizophrenia (see here). But there is also a recent study at Harvard Medical School, led by Ashley C. Proal, that has suggested this may not be the case. This recent comparison between families with a history of schizophrenia and those without, found […]

medicinepills

Omeros Reports Positive Results from New Medication Phase 2 Clinical Trial for Schizophrenia

by Staff Memberon March 17, 2014
A new research report gives hope to families and people who suffer from schizophrenia that there may soon be a new medication that helps with the negative and cognitive symptoms that are so common with schizophrenia. Omeros Corporation recently announced additional positive results from a Phase 2a clinical trial of OMS824, the company’s phosphodiesterase 10 (PDE10) […]